Effect of cytokines on the toxicity of cytostatic drugs to normal bone marrow cells in vitro

Cancer Chemotherapy and Pharmacology

Volumn 42, Issue 3, 1998, Pages 255-260

  Sundman Engberg, Britt ^a   Paul, Christer ^a   Tidefelt, Ulf ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

Author keywords

Anthracyclines; Ara C; Bone marrow; CFU GM; G CSF; GM CSF; IL 3; Normal hematopoietic cells

Indexed keywords

CYTARABINE; CYTOKINE; DAUNORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MITOXANTRONE;

ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TOXICITY;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CELL DIVISION; CHILD; CYTARABINE; CYTOKINES; DRUG INTERACTIONS; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; MIDDLE AGED; TUMOR STEM CELL ASSAY;

EID: 0031821574     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050814     Document Type: Article

References (29)

1. Bailey-Wood R, Dallimore CM, Whittaker JA (1984) Effect of adriamycin on CFU-Gm at plasma concentrations found following therapeutic infusions. Br J Cancer 50: 351-355
2. Bettleheim P, Valent P, Andreeff M, Tarufi A, Haimi J, Gorischek C, Muhm M, Sillaber C, Haas O, Vieder L, Maurer D, Schulz G, Speiser W, Geissler K, Kier P, Hinterberger W, Lechner K (1991) Recombinant human granulocyte-macrophage colony-stimulating factor in combination with Standard induction chemotherapy in de novo acute myeloid leukemia. Blood 77: 700-711
3. Bhalla K, Birkhofer M, Arlin Z, Grant S, Lutzky J, Graham G (1988) Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells. Leukemia 2: 810-813
4. Bhalla K, Holladay C, Arlin Z, Grant S, Ibrado AM, Jasiok M (1991) Treatment with interleukin-3 plus granuloeyte-macrophage colony-stimulating factor improves the selectivity of ara-C in vitro against acute myeloid leukemia blasts. Blood 78: 2674-2679
5. Böyum A (1968) Isolation of leukocytes from human blood. Further observations. Methylcellulose. dextran and Ficoll as erythrocyte aggregating agents. Scand J Clin Lab Invest 21: 31-50
6. Butturini A, Santucci AM, Gale RP, Perocco P, Tura S (1990) GM-CSF incubation prior to treatment with cytarabine or doxorubicin enhances drug activity against AML cells in vitro: a model for leukemia chemotherapy. Leuk Res 14: 743-749
7. Crespi MD, Ivanier SE, Genovese J, Baldi A (1986) Mitoxantrone affects topoisomerase activities in human breast cancer cells. Biochem Biophys Res Commun 136: 521-528
8. Dombret H, Chastang C, Faenaux P, Reiffers J, Bordessoule D, Bouabdallah R, Mandelli F, Ferrant A, Auzanneau G, Tilly H, Yver A, Degos L (1995) A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. N Engl J Med 332: 1678-1683
9. Estey E, Thall PF, Kantarjian H, O'Brian S, Koller CA, Beran M, Guiterman J, Deissenroth A, Keating M (1992) Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose Ara-C + daunorubicin: comparison with patients treated without GM-CSF. Blood 79: 2246-2255
10. Heil G, Chadid L, Hoelzer D, Seipelt G, Mitrou P, Hubert C, Kolbe K, Mertelsmann R, Lindemann A, Frisch J, Nicolay U, Gaus W, Heimpel H (1995) GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute leukemia (AML). Leukemia 9: 3-9
11. Kawano Y, Takaue Y, Saito S, Sato J, Shimizu T, Suzue T, Hirao A, Okamoto Y, Abe T, Watanabe T, Kuroda Y, Kimura F, Motoyoshi K, Asano S (1993) Granulocyte colony-stimulating factor (CSF), macrophage-CSF, granulocyte-macrophage CSF, interleukin-3, and interleukin-6 levels in sera from children undergoing blood stem cell autograft. Blood 81: 856-860
12. Liliemark J, Plunkett W (1986) Regulation of 1-b-D-arabinofuranosylcytosine 5′-triphosphate accumulation in human leukemia cells by deoxycytidine 5′-triphosphate. Cancer Res 46: 1079-1083
13. Liliemark J, Gahrton G, Paul C, Peterson C (1987) Ara-C in plasma and Ara-CTP in leukemic cells after subcutaneous injection and continuous intravenous infusion of Ara-C in patients with acute nonlymphoblastic leukemia. Semin Oncol 14 [Suppl 1]: 167-171
14. Lista P. Brizzi MF, Rossi M, Resegotti L, Clark C, Pegoraro L (1991) Different sensitivity of normal and leukaemic progenitor cells to Ara-C and IL-3 combined treatment. Br J Haematol 76: 21-26
15. Miyauchi J, Kelleher C, Wang C, Minkin S, McCulloch E (1989) Growth factors influence the sensitivity of leukemic stem cells to cytosinarabinoside in culture. Blood 73: 1272-1278
16. Pike BL, Robinson WA (1970) Human bone marrow colony growth in agar gel. J Cell Physiol 76: 77-84
17. Raza A, Khan SP, Medhi I, Imren S, Yasin Z, Preisler HD (1989) Cell cycle characteristics in myeloid leukemia. Bone Marrow Transplant 4: 26-29
18. Sallerfors B, Olofsson T, Lenhoff S (1991) Granulocyte-macrophage colony-stimulating factor (GM-CSF) and grunulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients. Bone Marrow Transplant 8: 191-195
19. Santini V, Nooter K, Delwel R, Löwenberg B (1990) Susceptibility of acute myeloid leukemia (AML) cells from clinically resistant and sensitive patients to daunomycin (DNR): assessment in vitro after stimulation with colony stimulating factors (CSFs). Leuk Res 14: 377-380
20. Seargeant LE, Kobrinsky NL, Sus CJ, Nazeravich DR (1987) In vitro stability and compatibility of daunorubicin. cytarabine and etoposide. Cancer Treat Rep 71: 1189-1192
21. Sieff CA (1987) Hematopoietie growth factors. J Clin Invest 79: 1549-1557
22. Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman P, Lee EJ, Moore JO, Powell BL, Schiller CA (1995) Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. N Engl J Med 332: 1671-1677
23. Sundman-Engberg B, Tidefelt U, Liliemark J, Paul C (1990) Intracellular concentrations of anticancer drugs in leukemic cells in vitro vs in vivo. Cancer Chemother Pharmacol 25: 252-256
24. Sundman-Engberg B, Tidefelt U, Paul C (1990) Effect of cytokines on the toxicity of cytostatic drugs on leukemic cells in vitro and in vivo. Eur J Haematol 56: 1-6
25. Sundman-Engberg B, Tidefelt U, Gruber A, Paul C (1993) Intracellular concentrations of mitoxantrone in leukemic cells in vitro vs in vivo. Leuk Res 17: 347-352
26. Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF (1984) Adriamycin-induced DNA damage by mammalian DNA topoisomerase II. Science 226: 466-468
27. Towatari M, Ito Y, Morishita Y, Tanimoto M, Kawashima K, Morishima Y, Andoh T, Saito H (1990) Enhanced expression of DNA topoisomerase II by recombinant human granulocyte colony-stimulating factor in human leukemia cells. Cancer Res 50: 7198-7202
28. Waga K, Furusawa S, Nagashima S, Saito K, Shishido H (1992) Comparative effects of G-CSF, GM-CSF and IL-3 on cytosine arabinoside- and daunorubicin-mediated cylotoxicity of acute myeloid leukemia cells and normal myeloid progenitors. Int J Hematol 56: 17-27
29. Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Moore MAS (1985) Purification and biochemical characterization of human pluripotent hemotopoietic colony-stimulating factor. Proc Natl Acad Sci USA 82: 1526-1530